Testing a Gene Therapy to Cure HIV & Fundamentally Change Healthcare with Jeff Galvin of American Gene Technologies‪®‬ From Lab to Launch by Qualio

Today, we are excited to chat with Jeff Galvin, CEO of American Gene Technologies®. We are so glad to have Jeff back on the show, we first spoke with him last March to learn about American Gene Technologies and what they were working on. I am excited to hear all the updates and accomplishments since we last chatted. Jeff is the CEO and founder of American Gene Technologies® (AGT).

He earned his BA degree in Economics from Harvard and has more than 30 years of business and entrepreneurial experience including founder or executive positions at various Silicon Valley startups. Following his startup experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement to found and fund AGT after meeting Roscoe Brady at NIH and the incredible projects he was working on in gene and cell therapy. Jeff has contagious energy for gene technology and the future of curing for the incurable like HIV, cancer, and PKU. 



Links:
www.americangene.com

https://www.linkedin.com/in/jeff-galvin-60258/

https://www.americangene.com/news-releases/agt-hiv-trial-enters-phase-withdrawing-antiretrovirals/ 


https://www.americangene.com/milestones/hiv-cure-countdown/

Qualio website:


https://www.qualio.com/


Previous episodes:


https://www.qualio.com/from-lab-to-launch-podcast


Apply to be on the show:


https://forms.gle/uUH2YtCFxJHrVGeL8


Music by keldez




Qualio website:
https://www.qualio.com/


Previous episodes:
https://www.qualio.com/from-lab-to-launch-podcast


Apply to be on the show:
https://forms.gle/uUH2YtCFxJHrVGeL8


Music by keldez